Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Quality of Life in Multiple Myeloma Patients Treated With Bortezomib
A completed clinical trial update examining quality of life in multiple myeloma patients treated with bortezomib.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating SGN-40 (brentuximab vedotin) in patients with refractory or …
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen [Phase 2]
A Phase 2 trial assessing stem cell transplantation using a reduced-toxicity myeloablative conditioning regimen for high-risk multiple myelo…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 study evaluating lenalidomide in Japanese patients with newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: IMGN901 in Combination With Lenalidomide and Dexamethasone [Phase 1]
Phase 1 trial evaluating IMGN901 in combination with lenalidomide and dexamethasone for multiple myeloma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating consolidation treatment with iodine-131 labeled tositumomab for multiple myeloma has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma [Phase 1, Phase 2]
Clinical trial update reports a Phase 1/2 study evaluating a combination of carfilzomib and lenalidomide with dexamethasone in newly diagnos…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating if monosialotetrahexosylganglioside (GM1) can prevent bortezomib-induced peripheral neuropathy in patients with mul…
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma Patients [Phase 2]
A phase 2 study comparing CNTO 328 (siltuximab) plus Velcade-Melphalan-Prednisone (VMP) to VMP alone in previously untreated multiple myelom…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy [Phase 3]
Phase 3 trial update of tandem high-dose melphalan with autologous stem cell transplant in multiple myeloma patients aged 60-70, comparing o…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives [Phase 2]
Phase 2 clinical trial investigating a two-step bone marrow transplant using cells from two partially matched relatives was terminated; resu…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma [Phase 3]
A Phase 3 study evaluated armodafinil for cancer-related fatigue in patients with multiple myeloma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]
This document reports an update on a Phase 1/2 study evaluating KW-2478 in combination with bortezomib for relapsed and/or refractory multip…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation [Phase 4]
This Phase 4 trial update reports the completion of the PROMPT study evaluating palifermin for reducing oral mucositis in peripheral blood s…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning [Phase 2]
A Phase 2 trial evaluating bortezomib (Velcade) in multiple myeloma patients before and after an allogeneic hematopoietic progenitor cell tr…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy [Phase 1]
Phase 1 safety study of CLT-008 human myeloid progenitor cells after cord blood transplantation for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps [Phase 1, Phase 2]
This Phase 1/2 study evaluated a two-step reduced-intensity conditioning regimen for bone marrow transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support [Phase 1]
A Phase 1 pharmacokinetic study of palifermin in patients receiving radiation therapy and chemotherapy followed by autologous blood stem cel…
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: FM 140 vs FM100 Study in Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial update comparing FM 140 with FM100 in patients with multiple myeloma; results were posted on 2014-10-17.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation [Phase 2]
Phase II trial evaluating the V-BEAM conditioning regimen before a second autologous stem cell transplantation in multiple myeloma was termi…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating the combination of SGN-40, lenalidomide, and dexamethasone in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma [Phase 3]
Phase 3 clinical trial evaluating high-dose melphalan with amifostine followed by autologous or syngeneic stem cell transplantation and main…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Study of Natalizumab in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating Natalizumab in relapsed/refractory multiple myeloma was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer [Phase 1]
Phase 1 clinical trial update reporting the completion of a study of EMD 121974 in patients with various locally advanced or metastatic canc…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection [Phase 2]
A Phase 2 clinical trial evaluating plerixafor in combination with chemotherapy and G-CSF for stem cell collection in patients with multiple…